| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/18/1997 | US5612032 Method for diagnosing tumors using mouse monoclonal antibodies |
| 03/18/1997 | US5612031 Dentistry |
| 03/18/1997 | US5612029 Tissue plasminogen activator glycosylation variants with improved therapeutic properties |
| 03/18/1997 | US5612016 Conjugates of antibodies and bifunctional ligands |
| 03/18/1997 | US5611971 Osmotic pressure adjustor in water with alcohol and sugars |
| 03/18/1997 | CA2096002C Compositions of digestive enzymes and salts of bile acids and process of preparation thereof |
| 03/15/1997 | CA2185517A1 Use of cytohesin-ph peptides for influencing the ability of integrins to adhere |
| 03/13/1997 | WO1997009441A2 Improved aav vectors for gene therapy |
| 03/13/1997 | WO1997009440A1 The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells |
| 03/13/1997 | WO1997009437A1 Materials and methods relating to the attachment and display of substances on cell surfaces |
| 03/13/1997 | WO1997009433A1 Cell-cycle checkpoint genes |
| 03/13/1997 | WO1997009430A2 A human metalloproteinase, variants thereof and dna sequences codding therefor |
| 03/13/1997 | WO1997009428A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 03/13/1997 | WO1997009427A1 Vegf-related protein |
| 03/13/1997 | WO1997009351A1 Recombinant anti-cd4 antibodies for human therapy |
| 03/13/1997 | WO1997009349A1 Binding protein |
| 03/13/1997 | WO1997009348A2 Orphan receptor |
| 03/13/1997 | WO1997009347A1 Cytolytic bradykinin antagonists |
| 03/13/1997 | WO1997009346A1 Des-arg9-bk antagonists |
| 03/13/1997 | WO1997009344A2 Librairies of backbone-cyclized peptidomimetics |
| 03/13/1997 | WO1997009343A2 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers |
| 03/13/1997 | WO1997009297A2 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 03/13/1997 | WO1997009068A2 Interactive molecular conjugates |
| 03/13/1997 | WO1997009065A1 Remedy for autoimmune disease |
| 03/13/1997 | WO1997009064A1 Use of muteins of wild-type cytokines as immunogens |
| 03/13/1997 | WO1997009063A1 Uses of tfpi inhibitor for treatment of cancer |
| 03/13/1997 | WO1997009062A1 Method of treating hypertension using animal stomach mucosa extract and endogenous protease-inhibitor peptides |
| 03/13/1997 | WO1997009061A1 Treatment of diabetes via administration of hormonally ineffective insulin |
| 03/13/1997 | WO1997009060A1 Method of treating insulin resistance |
| 03/13/1997 | WO1997009059A1 Lipid metabolism ameliorant |
| 03/13/1997 | WO1997009055A1 Isolation of microdomains of caveolae and gpi-anchored proteins |
| 03/13/1997 | WO1997009051A1 Analogs for specific oligosaccharide-neuregulin interactions and uses thereof |
| 03/13/1997 | WO1997009041A1 Method of treatment for eiph in racing stock |
| 03/13/1997 | WO1997009038A1 Diagnosis and treatment of neurological disease |
| 03/13/1997 | WO1997008934A2 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 03/13/1997 | WO1997005185A3 Multiblock biodegradable hydrogels for use as controlled release agents for drugs delivery and tissue treatment agents |
| 03/13/1997 | WO1997004795A3 Pharmaceutical compositions containing cyclosporin or other peptide substances |
| 03/13/1997 | WO1997004007A3 Metal-containing ribonucleotide polypeptides |
| 03/13/1997 | WO1997000601A3 Polypeptides with interleukin-8 receptor binding |
| 03/13/1997 | WO1996040784A3 Method of solubilizing, purifying, and refolding protein |
| 03/13/1997 | WO1996040767A3 E6ap-binding proteins |
| 03/13/1997 | WO1996040041A3 Antibodies to fas antigen capable of inhibiting apoptosis |
| 03/13/1997 | WO1996039500A3 Oligonucleotides specific for hepatitis c virus |
| 03/13/1997 | WO1996035453A3 Endothelin antagonists and endothelin synthase inhibitors for the prevention and treatment of interine contractility disorders, preeclampsia, atherosclerotic vascular disease, hypertension and or hormone replacement therapy |
| 03/13/1997 | WO1996034964A3 Stable variant hk2 polypeptide |
| 03/13/1997 | CA2684425A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 03/13/1997 | CA2653566A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 03/13/1997 | CA2231400A1 Vegf-related protein |
| 03/13/1997 | CA2231372A1 Materials and methods relating to the attachment and display of substances on cell surfaces |
| 03/13/1997 | CA2231190A1 Cell-cycle checkpoint genes |
| 03/13/1997 | CA2231182A1 Recombinant anti-cd4 antibodies for human therapy |
| 03/13/1997 | CA2230968A1 Method of treating insulin resistance |
| 03/13/1997 | CA2230907A1 Cytolytic bradykinin antagonists |
| 03/13/1997 | CA2230861A1 Libraries of backbone-cyclized peptidomimetics |
| 03/13/1997 | CA2230758A1 Improved aav vectors for gene therapy |
| 03/13/1997 | CA2230557A1 Interactive molecular conjugates |
| 03/13/1997 | CA2230385A1 Analogs for specific oliogosaccharide-neuregulin interactions and uses thereof |
| 03/13/1997 | CA2228667A1 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers |
| 03/13/1997 | CA2228604A1 Isolation of microdomains of caveolae and gpi-anchored proteins |
| 03/13/1997 | CA2227301A1 Hcv binding protein |
| 03/13/1997 | CA2224874A1 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 03/13/1997 | CA2184316A1 Buccal delivery system for therapeutic agents |
| 03/12/1997 | EP0761814A1 Antibody 103 B2 to a peanut agglutinin(PNA)-binding glycoprotein on cell surfaces |
| 03/12/1997 | EP0761688A2 Production, and therapeutic combinations, of antibodies |
| 03/12/1997 | EP0761686A2 Anticoagulant factor Va derivatives |
| 03/12/1997 | EP0761685A2 Macrophage-derived inflammatory mediator (mip-1 alpha and mip-1 beta) |
| 03/12/1997 | EP0761684A2 Alanine substitution analogues of magainin peptides |
| 03/12/1997 | EP0761683A1 Protein or polypeptide, process for producing the same, and intermediate compound tehrefor |
| 03/12/1997 | EP0761682A1 Cyclodepsipeptide |
| 03/12/1997 | EP0761233A2 Transkaryotic implantation |
| 03/12/1997 | EP0761231A1 Vaccine composition containing adjuvants |
| 03/12/1997 | EP0761229A1 Corneal vascularization inhibitor |
| 03/12/1997 | EP0761228A2 Gamma interferon containing composition for treatment of prurigo |
| 03/12/1997 | EP0761211A1 Sustained release composition |
| 03/12/1997 | EP0760864A1 Dna encoding glutamate gated chloride channels |
| 03/12/1997 | EP0760860A1 Methods of in vivo gene delivery |
| 03/12/1997 | EP0760858A1 Hybrid molecule of formula gm-csf-l-epo or epo-l-gm-csf for hematopoietic stimulation |
| 03/12/1997 | EP0760855A1 Hepatitis c virus asialoglycoproteins |
| 03/12/1997 | EP0760854A1 Lag1: a gene for increasing the longevity of eukaryotes |
| 03/12/1997 | EP0760849A1 Recombinant bpi-based and lbp-based proteins, nucleic acid molecules encoding same, methods of producing same, and uses thereof |
| 03/12/1997 | EP0760822A1 Anti-fungal cyclic depsipeptides |
| 03/12/1997 | EP0760813A1 Inhibitors of farnesyl-protein transferase |
| 03/12/1997 | EP0760685A1 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
| 03/12/1997 | EP0760682A1 Gene transfer-mediated angiogenesis therapy |
| 03/12/1997 | EP0760681A1 Modification of clostridial toxins for use as transport proteins |
| 03/12/1997 | EP0760677A1 A pharmaceutical preparation comprising glucagon |
| 03/12/1997 | EP0760676A1 Materials and methods for treatment of plaquing diseases |
| 03/12/1997 | EP0760675A1 Compositions comprising dna damaging agents and p53 |
| 03/12/1997 | EP0760674A1 Inhibition of infection of mammalian cells by respiratory syncytial virus |
| 03/12/1997 | EP0760673A1 INHIBITION OF ATTACHMENT OF $i(H. INFLUENZAE) TO HUMAN CELLS |
| 03/12/1997 | EP0760672A1 Angiotensin ii for improving fertilization |
| 03/12/1997 | EP0760671A1 Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines |
| 03/12/1997 | EP0760661A1 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies |
| 03/12/1997 | EP0760652A1 Compositions for neutralization of lipopolysaccharides |
| 03/12/1997 | EP0760602A1 Use of fas ligand to suppress lymphocyte-mediated immune responses |
| 03/12/1997 | EP0760601A1 Predicting fetal membrane rupture by mmp-9 activity |
| 03/12/1997 | EP0662081B1 Ureido-acetamide derivatives, preparation thereof and drugs containing same |
| 03/12/1997 | EP0644774A4 Improved production of reproductive hormones. |
| 03/12/1997 | EP0627001A4 Mammalian sos - a regulator/effector of tyrosine kinase signalling. |
| 03/12/1997 | EP0588873B1 Treatment of liver cancer |